Cargando…

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?

Detalles Bibliográficos
Autores principales:	Malvezzi, Paolo, Jouve, Thomas, Rostaing, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117737/ https://www.ncbi.nlm.nih.gov/pubmed/30097416 http://dx.doi.org/10.1016/j.ebiom.2018.07.032

Ejemplares similares

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
por: Vela, Carla, et al.
Publicado: (2022)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Corrigendum to Commentary “Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?” [EBioMedicine DOI: https://doi.org/10.1016/j.ebiom.2018.07.032]
Publicado: (2018)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2020)

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation
por: Bae, Hyunjoo, et al.
Publicado: (2023)

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review
por: Naciri Bennani, Hamza, et al.
Publicado: (2021)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
por: Cabezas, Lara, et al.
Publicado: (2022)

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring
por: Noble, Johan, et al.
Publicado: (2021)

The effect of BKV reactivation on cytokines behavior in kidney transplanted patients
por: Rahimi, Zahra, et al.
Publicado: (2022)

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
por: Terrec, Florian, et al.
Publicado: (2021)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
por: Papadopoulou, Anastasia, et al.
Publicado: (2021)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study
por: Jouve, Thomas, et al.
Publicado: (2022)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports
por: Laamech, Reda, et al.
Publicado: (2022)

BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2018)

Stepwise Reduction of Mycophenolate Mofetil with Conversion to Everolimus for the Treatment of Active BKV in Kidney Transplant Recipients: A Single-Center Experience in Vietnam
por: Kien, Truong Quy, et al.
Publicado: (2022)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients
por: Stervbo, Ulrik, et al.
Publicado: (2019)

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

1544. Kinetics of BK Virus in Urine Associated with BKV DNAemia and BKVAN in Pediatric Kidney Transplantation
por: Yamada, Masaki, et al.
Publicado: (2018)

Is Hyperparathyroidism a Concern for Allograft Dysfunction in Pediatric Kidney Transplantation?
por: Kaul, Sheena, et al.
Publicado: (2022)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival
por: Terrec, Florian, et al.
Publicado: (2021)

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood
por: Dave, Hema, et al.
Publicado: (2017)

Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case–control study
por: Gras, Julien, et al.
Publicado: (2023)

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients
por: Kamar, Nassim, et al.
Publicado: (2008)

Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022)

The association between polyomavirus BK strains and BKV viruria in liver transplant recipients
por: Wang, Robert Y. L., et al.
Publicado: (2016)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
por: Naciri Bennani, Hamza, et al.
Publicado: (2019)

Urine Exosomal bkv-miR-B1-5p and BK Virus Nephropathy in Kidney Transplant Recipients
por: Jung, Su Woong, et al.
Publicado: (2022)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
por: Legendre, Christophe
Publicado: (2019)

Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_835guhb53r6boq4hvjmkh5svnb